These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25583179)

  • 1. Guest editorial: mood disorders-preclinical, clinical and translational aspects.
    Olivier B
    Eur J Pharmacol; 2015 Apr; 753():1. PubMed ID: 25583179
    [No Abstract]   [Full Text] [Related]  

  • 2. Translational Perspectives in Treatment-Resistant Mood Disorders.
    Carvalho AF; McIntyre RS
    Curr Neuropharmacol; 2015; 13(5):556-7. PubMed ID: 26467406
    [No Abstract]   [Full Text] [Related]  

  • 3. Cortisol in mood disorders.
    Young AH
    Stress; 2004 Dec; 7(4):205-8. PubMed ID: 16019585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical and clinical studies with corticotropin-releasing factor: implications for affective disorders.
    Owens MJ; Nemeroff CB
    Psychopharmacol Bull; 1988; 24(3):355-9. PubMed ID: 3153493
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial.
    Kasper S
    World J Biol Psychiatry; 2014 Feb; 15(2):83. PubMed ID: 24506288
    [No Abstract]   [Full Text] [Related]  

  • 6. Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs.
    Tardito D; Mallei A; Popoli M
    Expert Opin Investig Drugs; 2013 Feb; 22(2):217-33. PubMed ID: 23253113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating experimental neuroscience into treatment of eating disorders: two examples.
    Schmidt U; Oldershaw A; van Elburg A
    Curr Top Behav Neurosci; 2011; 6():253-68. PubMed ID: 21243480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of placebo in clinical trials of mood disorders.
    Lewis L
    J Am Acad Child Adolesc Psychiatry; 2003 Aug; 42(8):883. PubMed ID: 12874487
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacopsychiatry. Editorial.
    Tretter F; Rujescu D; Turck CW; Mewes HW
    Pharmacopsychiatry; 2011 May; 44 Suppl 1():S1. PubMed ID: 21544740
    [No Abstract]   [Full Text] [Related]  

  • 10. Special Section Guest Editorial: Translational biophotonics.
    Apiou-Sbirlea G; Evans CL; Kelly KM; Tromberg BJ
    J Biomed Opt; 2016 Dec; 21(12):124002. PubMed ID: 27999859
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy and use of anticonvulsants in mood disorders.
    Dunn RT; Frye MS; Kimbrell TA; Denicoff KD; Leverich GS; Post RM
    Clin Neuropharmacol; 1998; 21(4):215-35. PubMed ID: 9704164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiaxial evaluation of the pathophysiology of mood disorder and therapeutic mechanisms of clinical drugs by neuronal plasticity and neuronal load].
    Omata N; Mizuno T; Mitsuya H; Wada Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):231-6. PubMed ID: 25069263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of mood disorders.
    Wittchen HU
    Science; 2012 Oct; 338(6103):15. PubMed ID: 23042853
    [No Abstract]   [Full Text] [Related]  

  • 14. Weight gain mitigation with topiramate in mood disorders.
    Woods TM; Eichner SF; Franks AS
    Ann Pharmacother; 2004 May; 38(5):887-91. PubMed ID: 15039481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
    Manji HK; Duman RS
    Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular signaling pathways pave roads to recovery for mood disorders.
    Tanis KQ; Duman RS
    Ann Med; 2007; 39(7):531-44. PubMed ID: 17852035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings for the 5th workshop for the Biochemical and Pharmacological Research on Affective Disorders. May 26-27, 1989, Tokyo.
    Jpn J Psychiatry Neurol; 1990 Mar; 44(1):123-57. PubMed ID: 2362387
    [No Abstract]   [Full Text] [Related]  

  • 18. Mood stabilizers for patients with bipolar disorder: the state of the art.
    Altamura AC; Lietti L; Dobrea C; Benatti B; Arici C; Dell'Osso B
    Expert Rev Neurother; 2011 Jan; 11(1):85-99. PubMed ID: 21158558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational research approach to biological and modifiable risk factors of psychosis and affective disorders.
    Baune BT; Thome J
    World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():28-34. PubMed ID: 21905992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
    Brady KT; Verduin ML
    Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.